Pemphigus - 25 Studies Found

Terminated : Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
: Pemphigus
: 2011-03-10
: Drug: Sirolimus (formerly known as Rapamycin) For low to moderate immunologic risk, the loading dose is
Terminated : Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
: Pemphigus
: 2011-04-17
: Drug: Rituximab intravenous (IV) Rituximab 1 gramX2, every (q) 2 weeks.
Terminated : Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
: Pemphigus
: 2015-11-23
:
  • Drug: Ofatumumab Ofatumumab (h
Completed : Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
: Pemphigus Vulgaris
: 2013-08-23
:
  • Drug: VAY736 VAY736 will be ad
Completed : Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
: Pemphigus
: 2011-02-17
: Drug: Rituximab 375mg/m2 Other Name: Mabthéra
Completed : Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
: Pemphigus
: 2013-10-04
: Drug: Rituximab and Cyclophosphamide IV
Completed : Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
: Pemphigus Vulgaris
: 2008-02-21
:
  • Drug: Azathioprine It is given
Completed : European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
: Pemphigus
: 2005-08-04
: Drug: dexamethasone (50mg 1dd6, 3 consecutive days/month)
Terminated : Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
: Pemphigus Vulgaris
: 2007-06-05
:
  • Drug: intravenous immunoglobulin

Completed : Effect of Anti CD20 in Pemphigus Desease
: Pemphigus
: 2005-09-13
: Drug: Mabthera
Next >>>